News archive for The Department of Biomedicine
Stroke patients have particular high risk of thrombotic events caused by platelet (thrombocyte) activation, which may lead to new infarctions. Secondary treatment of these patients with anti-platelet therapy consisting of aspirin and dipyridamole is therefore a common protocol.
- November 2024 (1)
- February 2024 (1)
- November 2023 (1)
- September 2023 (1)
- August 2023 (1)
- July 2023 (1)
- March 2023 (2)
- January 2023 (1)
- December 2022 (1)
- March 2022 (1)
- February 2022 (1)
- January 2022 (1)
- December 2021 (1)
- September 2021 (1)
- August 2021 (2)
- July 2021 (1)
- May 2021 (1)
- March 2021 (1)
- February 2021 (2)
- November 2020 (1)
- October 2020 (1)
- September 2020 (3)
- August 2020 (1)
- April 2020 (1)
- March 2020 (1)
- February 2020 (2)
- January 2020 (1)
- December 2019 (1)
- June 2019 (1)
- May 2019 (2)
- March 2019 (1)
- January 2019 (1)
- November 2018 (1)
- October 2018 (3)
- September 2018 (1)
- March 2018 (1)
- September 2017 (1)
- February 2017 (1)
- January 2014 (1)
- November 2013 (1)
- October 2013 (2)
- October 2010 (1)